Solid state beta-sensitive surgical probe

• US 6,076,009 A
• Filed: 05/05/1997
• Issued: 06/13/2000
• Est. Priority Date: 05/05/1997
• Status: Expired due to Term

• Current Assignee: University of Alabama (University of Alabama System)
• Original Assignee: University of Michigan
• Inventors: Wahl, Richard L., Raylman, Raymond R.
• Primary Examiner(s): Casler, Brian L.
• Application Number:
  US08/850,452
• Time in Patent Office: 1,135 Days
• Field of Search: 600/436, 600/407, 600/431, 250/367, 250/368, 250/366, 250/308, 250/303, 250/486.1, 250/482.1, 250/370.11, 250/370.14
• US Class Current: 600/436
• CPC Class Codes: A61B 6/425 using detectors specially adapted to be used in the interior of the body
• CPC Class Codes: A61B 6/4258 for detecting non x-ray radiation, e.g. gamma radiation A61B6/037 takes precedence
• CPC Class Codes: G01T 1/161 Applications in the field of nuclear medicine, e.g. in vivo counting apparatus for radiation diagnosis A61B6/00

Abstract

An intraoperative probe system for preferentially detecting beta radiation over gamma radiation emitted from a radiopharmaceutical is described. In one embodiment, the probe system of the present invention is a probe having an ion-implanted silicon charged-particle detector for generating an electrical signal in response to received beta particles. In such an embodiment, a preamplifier may be located in close proximity to the detector filters and amplifies the electrical signal. Furthermore, a wire may be used to couple the probe to a processing unit for amplifying and filtering the electrical signal, and a counter may be utilized to analyze the resulting electrical signal to determine the number of beta particles being received by the detector. Alternatively, the wire can be replaced with an infrared or radio transmitter and receiver for wireless operation of the probe.

Claims

1. A method for detecting radiopharmaceuticals within diseased tissue, comprising:

a) providing;

1) a patient having a region of diseased tissue,

2) a radiopharmaceutical capable of emitting beta particles, and

3) a device comprising a housing having a rear portion and a front portion, said front portion comprising a tip with first and second radiation detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector;

b) administering said radiopharmaceutical to said patient; and

c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.

2. The method of claim 1, wherein said first and second detectors are semiconductor detectors.

3. The method of claim 2, wherein said semiconductor detectors are ion-implanted silicon detectors.

4. The method of claim 2, wherein said semiconductor detectors are surface barrier detectors.

5. The method of claim 1, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.

6. The method of claim 1, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.

7. The method of claim 6, wherein said preamplifiers are both connected to a power supply.

8. The method of claim 1, wherein said device further comprises a radiation entrance window defining said tip and the end of the front portion of said housing.

9. The method of claim 8, wherein said radiation entrance window permits the transmission of gamma radiation and wherein the remainder of the housing blocks the transmission of gamma radiation.

10. The method of claim 9, wherein said radiation entrance window comprises aluminum.

11. A method for detecting radiopharmaceuticals within diseased tissue, comprising:

a) providing;

1) a patient having a region of diseased tissue,

2) a radiopharmaceutical capable of emitting beta particles and gamma radiation, and

3) a device comprising

i) an elongated housing, said housing comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip, and

ii) first and second semiconductor detectors disposed within said housing at said tip, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector;

b) administering said radiopharmaceutical to said patient; and

c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.

12. The method of claim 11, wherein said device further comprises a radiation entrance window defining said tip and the end of the front portion of said housing.

13. The method of claim 11, wherein said semiconductor detectors are ion-implanted silicon detectors.

14. The method of claim 11, wherein said semiconductor detectors are surface barrier detectors.

15. The method of claim 11, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.

16. The method of claim 11, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.

17. The method of claim 16, wherein said preamplifiers are both connected to a power supply.

18. A method for detecting radiopharmaceuticals within diseased tissue, comprising:

a) providing;

1) a patient having a region of diseased tissue,

2) a radiopharmaceutical capable of emitting beta particles, and

3) a device comprising;

i) an elongated housing, comprising a hand-graspable rear portion and a front portion, said front portion comprising a cylindrical tip having a radiation entrance window, wherein said radiation entrance window permits the transmission of gamma radiation and wherein the remainder of the housing blocks the transmission of gamma radiation, and

ii) first and second semiconductor radiation detectors disposed within said housing at said tip, wherein said first detector is positioned in front of said second detector relative to said radiation entrance window in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector;

b) administering said radiopharmaceutical to said patient; and

c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.

19. The method of claim 18, wherein said silicon-based detectors are ion-implanted silicon detectors.

20. The method of claim 18, wherein said silicon-based detectors are surface barrier detectors.

21. The method of claim 18, wherein said first and second detectors comprise circular silicon wafers of identical dimensions.

22. The method of claim 18, wherein said device further comprises first and second preamplifiers contained within said housing, said first preamplifier coupled to said first detector and said second preamplifier coupled to said second detector.

23. The method of claim 22, wherein said preamplifiers are both connected to a power supply.

24. A method for detecting radiopharmaceuticals within diseased tissue, comprising:

a) providing;

1) a patient having a region of diseased tissue,

2) a radiopharmaceutical capable of emitting beta particles, and

3) a device comprising;

i) a probe having a first radiation detector which generates an electrical signal in response to the passage of radiation into said first detector from a radiopharmaceutical in diseased tissue, and a second radiation detector, said first detector capable of detecting beta particles and gamma radiation and serving to shield said second detector from at least a portion of the beta particles detected by said first detector, wherein said first detector is positioned in front of said second detector in a manner such that radiation reaching said tip of said device contacts said first detector prior to contacting said second detector; and

ii) an optical transmitter coupled to said probe for transmitting said electrical signal as an optical signal to a remote location; and

b) administering said radiopharmaceutical to said patient; and

c) detecting beta particles emitted from said radiopharmaceutical with said device within said region of said patient.